Overview

Graves' Disease Remission Study: MycoMeth Combo

Status:
Recruiting
Trial end date:
2026-10-08
Target enrollment:
Participant gender:
Summary
A randomized study to evaluate the efficacy and safety of combining mycophenolate mofetil with methimazole in patients with newly diagnosed Graves' disease.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
The First Affiliated Hospital of Xiamen University
Treatments:
Methimazole
Mycophenolic Acid